40 results
8-K
EX-10.1
GALT
Galectin Therapeutics Inc.
1 Aug 24
Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer
7:50am
in possession of selective or specialized skills, learning, or abilities or customer contacts or customer information who has obtained such skills … and each customer or potential customer of the Company: (i) with whom or which Executive dealt on behalf of the Company; (ii) whose dealings
8-K
EX-10.1
GALT
Galectin Therapeutics Inc.
2 Sep 20
Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer
7:51am
in possession of selective or specialized skills, learning, or abilities or customer contacts or customer information who has obtained such skills … and each customer or potential customer of the Company: (i) with whom or which Executive dealt on behalf of the Company; (ii) whose dealings
8-K
EX-10.4
GALT
Galectin Therapeutics Inc.
2 Sep 20
Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer
7:51am
recruit, solicit or otherwise induce or influence any lessor, supplier, customer, agent, representative or any other person that has a business
8-K
EX-10.1
GALT
Galectin Therapeutics Inc.
20 Feb 20
Galectin Therapeutics Appoints Seasoned Biopharmaceutical Executive
7:55am
or customer contacts or customer information who has obtained such skills, learning, abilities, contacts, or information by reason of having worked … for the Company. (e) “Material Contact” shall mean the contact between Executive and each customer or potential customer of the Company: (i) with whom or which
FWP
10huzmy
10 May 19
Free writing prospectus
8:02am
8-K
EX-99.1
qan1hpe agef2
10 May 19
Other Events
7:59am
S-8
EX-99.1
447 62xepsm5
26 Jun 18
Registration of securities for employees
4:17pm
8-K
EX-10.1
jdufe
12 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
nbr5g65
25 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
7ty0afp3y 0wv9s82vo
21 Sep 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
9qtvyti81541u4r0em
25 Jul 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
wdpyztljn38ji0
1 May 12
Galectin Therapeutics Announces Long-term Engagement of Dr. Scott Friedman to Advise on Liver Fibrosis Programs
12:00am
8-K
EX-10.1
e6qny 2hj05l01oidx5
5 Mar 12
Appoints Thomas A. Mcgauley As Acting Chief Financial Officer and Extends Term of Employment of Maureen E. Foley As Chief Operating Officer
12:00am
8-K
EX-10.2
wpn9 88i2
20 Dec 11
Other Events
12:00am
8-K
EX-10.1
x2wgjg7pe90vvn 8oeh
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am